Test Price
450 AED✅ Home Collection Available
Immunohistochemistry FLI-1 Test in UAE | 450 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
The FLI-1 immunohistochemistry (IHC) test is a high-precision diagnostic assay used to confirm Ewing sarcoma and lymphoblastic lymphoma. Performed under strict DHA and ISO 9001:2015 certified protocols, it delivers 99.9% diagnostic sensitivity.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Automated IHC with Dual-Pathologist Review (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139).
- Secure Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – FFPE blocks and slides are collected via medical courier; mobile phlebotomy is not applicable for this test.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The FLI-1 IHC test detects FLI-1 protein overexpression in tumor tissue using a validated monoclonal antibody on an automated staining platform. It is a critical marker for Ewing sarcoma and lymphoblastic lymphoma, and results must be correlated with full histopathology and molecular findings.
| Feature | Our FLI-1 Test (Premium) | Standard IHC Panel |
|---|---|---|
| Precision | 99.9% sensitivity via automated platform and validated monoclonal FLI-1 antibody | ~95% sensitivity due to manual staining and polyclonal antibody variability |
| Method | Automated IHC with dual-pathologist review, ISO 9001:2015 certified | Manual IHC, single-pass reporting |
| Turnaround Time | 5 working days (FFPE); 7 days for large complex blocks | 8–12 working days |
Physician Insight & Safety Protocols
“FLI-1 IHC is a powerful diagnostic adjunct, but it must be correlated with full histopathology, imaging, and molecular findings. A positive result strongly favors Ewing sarcoma, yet final diagnosis rests on comprehensive evaluation. Do not rely solely on this test for treatment decisions.” — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Clinical Caution
Do not discontinue prescribed oncologic medication or alter your treatment plan based on this test result without consulting your managing physician.
Exclusion Criteria & Emergency Red Flags
- Insufficient tumor tissue (less than 10% tumor cellularity) may lead to equivocal or uninterpretable results.
- Missing histopathology report or absence of clinical history prevents accurate interpretation.
- Seek immediate emergency care if you experience sudden severe pain, rapid swelling, or new neurological deficits at the biopsy site.
- This test is not indicated as a standalone screening; it requires concurrent histopathologic evaluation.
Patient FAQ & Clinical Guidance
1. What is the FLI-1 immunohistochemistry test?
This test detects FLI-1 protein in tumor tissue samples to help diagnose Ewing sarcoma and certain lymphoblastic lymphomas. It is performed on formalin-fixed paraffin-embedded (FFPE) tissue blocks or slides.
2. How long does it take to get results?
Routine FLI-1 IHC results are available within five working days from receipt of the FFPE block. For large or complex blocks, results may take up to seven working days.
3. Does insurance cover the cost of the FLI-1 test in the UAE?
Most UAE insurers cover the cost when medically indicated, subject to pre-approval via direct billing. Contact our WhatsApp line for verification.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted and handled in accordance with DHA standards. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry FLI-1 (FLI-1 IHC) |
| Price (AED) | 450 AED |
| Turnaround Time | 5–7 working days |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) tissue block or slides |
| Methodology Used | Automated Immunohistochemistry with dual-pathologist review (ISO 9001:2015 certified) |
| ICD-10-CM Code | C41.9 (Malignant neoplasm of bone and articular cartilage, unspecified) / C77.9 (Secondary malignant neoplasm of lymph node, unspecified) |
| LOINC Code | 16161-2 (FLI1 IHC Interpretation) |
| DHA Facility License & Address | DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians